[go: up one dir, main page]

AR046770A1 - Derivados bencimidazol 5- o 6-substituidos como inhibidores de la replicacion del virus sincitial respiratorio - Google Patents

Derivados bencimidazol 5- o 6-substituidos como inhibidores de la replicacion del virus sincitial respiratorio

Info

Publication number
AR046770A1
AR046770A1 ARP040104808A ARP040104808A AR046770A1 AR 046770 A1 AR046770 A1 AR 046770A1 AR P040104808 A ARP040104808 A AR P040104808A AR P040104808 A ARP040104808 A AR P040104808A AR 046770 A1 AR046770 A1 AR 046770A1
Authority
AR
Argentina
Prior art keywords
het
alkyl
hydrogen
replication
substituted
Prior art date
Application number
ARP040104808A
Other languages
English (en)
Original Assignee
Tibotec Pharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tibotec Pharm Ltd filed Critical Tibotec Pharm Ltd
Publication of AR046770A1 publication Critical patent/AR046770A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

La presente se refiere a derivados de bencimidazol 5- o 6-sustituidos que tienen actividad inhibidora sobre la replicación sobre el virus sincitial respiratorio y que tienen la formula (1), profármacos, N-oxido, sal de adición, amina cuaternaria, complejo metálico o forma estereoquímicamente isomérica del mismo donde Q es Ar2, R6a, pirrolidinilo substituido con R6, piperidinilo substituido con R6 u homopiperidinilo con R6; G es un enlace directo o un alcanodiilo C1-10 opcionalmente sustituido; R1 es Ar1 o un heterociclo monocíclico o bicíclico; uno de R2a y R2b es cianoalquilo C1-6, cianoalquenilo C2-6, Ar3-alquilo C1-6, Het-alquilo C1-6, N(R8aR8b)alquilo C1-6, Ar3-alquenilo C2-6, Het-alquenilo C2-6, Ar3-aminoalquilo C1-6, Het- aminoalquilo C1-6, Ar3-tioalquilo C1-6, Het-tioalquilo C1-6, Ar3-sulfonilalquilo C1-6, Het-sulfonilalquilo C1-6, Ar3-aminocarbonilo, Het-aminocarbonilo, Ar3(CH2)naminocarbonilo, Het-(CH2)naminocarbonilo, Ar3-carbonilamino, Het-carbonilamino, Ar3(CH2)ncarbonilamino, Y otro de R2a y R2b es hidrógeno; en el caso de que R2a sea hidrógeno, entonces R3 es hidrógeno; en el caso de que R2b sea hidrógeno, entonces R3 es hidrógeno o alquilo C1-6. Se refiere además a su preparación y a las composiciones que los comprenden así como también a su uso como medicamento.
ARP040104808A 2003-12-18 2004-12-20 Derivados bencimidazol 5- o 6-substituidos como inhibidores de la replicacion del virus sincitial respiratorio AR046770A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03104806 2003-12-18
US56686704P 2004-04-30 2004-04-30

Publications (1)

Publication Number Publication Date
AR046770A1 true AR046770A1 (es) 2005-12-21

Family

ID=43646156

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP040104808A AR046770A1 (es) 2003-12-18 2004-12-20 Derivados bencimidazol 5- o 6-substituidos como inhibidores de la replicacion del virus sincitial respiratorio

Country Status (19)

Country Link
US (2) US20070093502A1 (es)
EP (1) EP1697347B1 (es)
JP (1) JP2007514719A (es)
KR (1) KR101123055B1 (es)
CN (1) CN1914196B (es)
AR (1) AR046770A1 (es)
AT (1) ATE499361T1 (es)
AU (1) AU2004298459B2 (es)
BR (1) BRPI0417273A (es)
CA (1) CA2548793A1 (es)
DE (1) DE602004031555D1 (es)
DK (1) DK1697347T3 (es)
HR (1) HRP20110313T1 (es)
MX (1) MXPA06007111A (es)
MY (1) MY142783A (es)
RU (1) RU2369606C2 (es)
SI (1) SI1697347T1 (es)
TW (1) TWI382981B (es)
WO (1) WO2005058874A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2419613C2 (ru) * 2005-06-20 2011-05-27 Тиботек Фармасьютикалз Лтд Гетероциклиламиноалкилзамещенные бензимидазолы
TWI605043B (zh) 2011-10-14 2017-11-11 安比特生物科學公司 雜環化合物及其使用方法
TW201825465A (zh) 2016-09-23 2018-07-16 美商基利科學股份有限公司 磷脂醯肌醇3-激酶抑制劑
TW201815787A (zh) 2016-09-23 2018-05-01 美商基利科學股份有限公司 磷脂醯肌醇3-激酶抑制劑
TW201813963A (zh) 2016-09-23 2018-04-16 美商基利科學股份有限公司 磷脂醯肌醇3-激酶抑制劑
JP6594570B2 (ja) 2017-03-20 2019-10-23 フォーマ セラピューティクス,インコーポレイテッド ピルビン酸キナーゼ(pkr)活性化剤としてのピロロピロール組成物
CA3079607A1 (en) 2017-10-19 2019-04-25 Effector Therapeutics, Inc. Benzimidazole-indole inhibitors of mnk1 and mnk2
WO2020061378A1 (en) 2018-09-19 2020-03-26 Forma Therapeutics, Inc. Treating sickle cell disease with a pyruvate kinase r activating compound
WO2020061255A1 (en) 2018-09-19 2020-03-26 Forma Therapeutics, Inc. Activating pyruvate kinase r
AU2020350763A1 (en) 2019-09-19 2022-04-07 Novo Nordisk Health Care Ag Pyruvate kinase R (PKR) activating compositions
US12128035B2 (en) 2021-03-19 2024-10-29 Novo Nordisk Health Care Ag Activating pyruvate kinase R

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4025621A (en) * 1975-01-09 1977-05-24 Purdy Clarence L Method of curing and providing immunity from viral infections
CA1140119A (en) 1978-04-03 1983-01-25 Joseph Torremans N-heterocyclyl-4-piperidinamines
US4556660A (en) 1982-07-12 1985-12-03 Janssen Pharmaceutica N.V. N-(Bicyclic heterocyclyl)-4-piperidinamines
US4634704A (en) 1983-10-06 1987-01-06 Janssen Pharmaceutica, N.V. Anti-allergic five membered heterocyclic ring containing N-(bicyclic heterocycyl)-4-piperidinamines
NZ223654A (en) * 1987-03-09 1990-03-27 Janssen Pharmaceutica Nv 1-alkyl-substituted-benzimidazole-4-piperidinamines and pharmaceutical compositions
KR100190299B1 (ko) 1990-07-19 1999-06-01 디르크 반테 신규한 옥사졸릴 유도체
CZ20014573A3 (cs) * 1999-06-28 2002-05-15 Janssen Pharmaceutica N. V. Inhibitory replikace respiračně syncyciálního viru
ES2215683T3 (es) * 1999-06-28 2004-10-16 Janssen Pharmaceutica N.V. Inhibidores de la replicacion del virus sincitial respiratorio.
EP1418175A1 (en) * 1999-06-28 2004-05-12 Janssen Pharmaceutica N.V. Respiratory syncytial virus replication inhibitors
JP2004532856A (ja) * 2001-04-30 2004-10-28 藤沢薬品工業株式会社 アポリポタンパク質b阻害剤としてのビアリールカルボキサミド化合物
US7030150B2 (en) * 2001-05-11 2006-04-18 Trimeris, Inc. Benzimidazole compounds and antiviral uses thereof
FR2833948B1 (fr) * 2001-12-21 2004-02-06 Sod Conseils Rech Applic Nouveaux derives de benzimidazole et leur utilisation en tant que medicament

Also Published As

Publication number Publication date
DE602004031555D1 (de) 2011-04-07
EP1697347A1 (en) 2006-09-06
US20090062278A1 (en) 2009-03-05
CN1914196A (zh) 2007-02-14
KR20060127047A (ko) 2006-12-11
DK1697347T3 (da) 2011-06-06
US8278455B2 (en) 2012-10-02
SI1697347T1 (sl) 2011-06-30
TWI382981B (zh) 2013-01-21
CN1914196B (zh) 2012-01-25
HRP20110313T1 (hr) 2011-05-31
RU2369606C2 (ru) 2009-10-10
AU2004298459A1 (en) 2005-06-30
JP2007514719A (ja) 2007-06-07
TW200531970A (en) 2005-10-01
BRPI0417273A (pt) 2007-03-27
US20070093502A1 (en) 2007-04-26
MXPA06007111A (es) 2006-08-23
WO2005058874A1 (en) 2005-06-30
AU2004298459B2 (en) 2011-03-17
CA2548793A1 (en) 2005-06-30
EP1697347B1 (en) 2011-02-23
KR101123055B1 (ko) 2012-04-12
MY142783A (en) 2010-12-31
RU2006125727A (ru) 2008-01-27
ATE499361T1 (de) 2011-03-15

Similar Documents

Publication Publication Date Title
MX383688B (es) Derivados de piridona amida como agonistas de canales de sodio nav1. 8 y el uso de los mismos en el tratamiento de dolor.
ECSP105253A (es) Derivados de 5-feniltiazol y uso como inhibidores de pi3 cinasa
MX2009012613A (es) Tiazoles substituidos por heteroarilo y su uso como agentes antivirales.
PH12016500553B1 (en) Substituted quinolizine derivatives useful as hiv integrase inhibitors
TR201810944T4 (tr) Fgfr4 inhibitörleri olarak halka-füzyonlu bisiklik piridil türevleri.
PH12012500752A1 (en) Benzimidazole-imidazole derivatives
AR046959A1 (es) Morfolinilo que contiene bencimidazoles como inhibidores de la replicacion del virus sincitial respiratorio
AR035991A1 (es) Derivados de benzimidazoles e imidazopiridinas, un procedimiento para su preparacion, composiciones farmaceuticas, un procedimiento para su preparacion, y un medicamento utiles como inhibidores de la replicacion del virus sincitial respiratorio
IS8503A (is) Azatvíhringja heteróhringir sem kannabínóníð-viðtakastillar
MX2015012432A (es) Inhibidores piridinicos de la cinasa cdk9.
TW200626154A (en) Heterocyclic derivatives and their use as therapeutic agents
ECSP109903A (es) Derivados de pirazinona y su uso en el tratamiento de enfermedades pulmonares
TW200626153A (en) Heterocyclic derivatives and their use as therapeutic agents
TW200626592A (en) Heterocyclic derivatives and their use as therapeutic agents
BR112014006840A2 (pt) derivados de pirrolopirimidina e purina
TW200626139A (en) Heterocyclic derivatives and their use as therapeutic agents
MX2007003546A (es) Derivados de indozolona como inhibidores de 11-beta- hidroxiesteroide-deshidrogenasa.
PH12016500911A1 (en) 2,6-substituted purine derivatives and their use in the treatment of proliferative disorders
AR078278A1 (es) Antagonistas de la tiazol y oxazol hepcidina, composiciones farmaceuticas que los contienen y uso de los mismos para el tratamiento de anemias y enfermedades asociadas a deficiencias de hierro.
AR041545A1 (es) Derivados sustituidos de 1,4-di-piperidin-4 il-piperazina y su uso como antagonistas de neuroquininas
BRPI0507312A (pt) derivados de quinolina para uso como inibidores micobacterianos
UA117151C2 (uk) N-ациліміногетероциклічні сполуки
AR046770A1 (es) Derivados bencimidazol 5- o 6-substituidos como inhibidores de la replicacion del virus sincitial respiratorio
MY173573A (en) Pyridin-4-yl derivatives
ECSP099506A (es) Derivados de 2-quinolinona y 2 quinoxalinona y su utilización como agentes anti bacterianos

Legal Events

Date Code Title Description
FA Abandonment or withdrawal